Headlines
J&J-backed HistoSonics explores sale at $2.5 billion valuation, FT reports
J&J-backed HistoSonics explores sale at $2.5 billion valuation, FT reports
Published by Global Banking and Finance Review
Posted on May 2, 2025

Published by Global Banking and Finance Review
Posted on May 2, 2025

(Reuters) -HistoSonics, a medical technology company backed by Johnson & Johnson, is exploring a potential sale after receiving multiple takeover approaches, the Financial Times reported on Friday, citing people familiar with the matter.
The company is seeking a valuation of more than $2.5 billion, the report said.
(Reporting by Bipasha Dey in Bengaluru; Editing by Sonia Cheema)
Explore more articles in the Headlines category



